In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
- PMID: 37665996
- DOI: 10.7326/J23-0068
In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
Abstract
Anand A, Mathew SJ, Sanacora G, et al. Ketamine versus ECT for nonpsychotic treatment-resistant major depression. N Engl J Med. 2023;388:2315-2325. 37224232.
Conflict of interest statement
Comment on
-
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.N Engl J Med. 2023 Jun 22;388(25):2315-2325. doi: 10.1056/NEJMoa2302399. Epub 2023 May 24. N Engl J Med. 2023. PMID: 37224232 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources